Detalhe da pesquisa
1.
Enzymes involved in tumor-driven angiogenesis: A valuable target for anticancer therapy.
Semin Cancer Biol
; 56: 87-99, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29128510
2.
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial.
Lancet Oncol
; 19(4): 474-485, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29482983
3.
Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting.
Oncologist
; 22(6): 648-654, 2017 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28432226
4.
Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy.
BMC Cancer
; 17(1): 502, 2017 Jul 26.
Artigo
Inglês
| MEDLINE | ID: mdl-28747156
5.
Adherence to oral hormonal anticancer agents in breast cancer.
Tumori
; 109(3): 262-268, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-35603579
6.
[Hormone therapy, cardio-metabolic profile, and cardiotoxicity. Still a dark side of cardio-oncology - Part 2: Prostate cancer]. / Terapia ormonale, assetto cardio-metabolico e cardiotossicità. Il lato ancora oscuro della cardioncologia Parte 2: Tumore della prostata.
G Ital Cardiol (Rome)
; 24(10): 781-791, 2023 Oct.
Artigo
Italiano
| MEDLINE | ID: mdl-37767830
7.
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study.
Front Oncol
; 13: 1152123, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37260975
8.
Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study.
BMC Cancer
; 12: 158, 2012 Apr 30.
Artigo
Inglês
| MEDLINE | ID: mdl-22545982
9.
[Hormone therapy, cardio-metabolic profile and cardiotoxicity. Still a dark side of cardio-oncology. Part 1: Breast cancer]. / Terapia ormonale, assetto cardio-metabolico e cardiotossicità. Il lato ancora oscuro della cardioncologia Parte 1: Cancro della mammella.
G Ital Cardiol (Rome)
; 23(4): 286-294, 2022 Apr.
Artigo
Italiano
| MEDLINE | ID: mdl-35343480
10.
Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study.
Clin Breast Cancer
; 21(5): e489-e496, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33342749
11.
Pharmacokinetics of trastuzumab in haemodialysis.
Breast J
; 21(3): 329-31, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25790224
12.
Prevalence and Spectrum of BRCA Germline Variants in Central Italian High Risk or Familial Breast/Ovarian Cancer Patients: A Monocentric Study.
Genes (Basel)
; 11(8)2020 08 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32806537
13.
The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer.
Clin Breast Cancer
; 19(4): e501-e510, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31204290
14.
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study.
Cancer Biol Ther
; 20(2): 192-200, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-30403909
15.
Sensitivity and specificity of breast cancer ICD-9-CM codes in three Italian administrative healthcare databases: a diagnostic accuracy study.
BMJ Open
; 8(7): e020627, 2018 07 23.
Artigo
Inglês
| MEDLINE | ID: mdl-30037866
16.
Emerging enzymatic targets controlling angiogenesis in cancer: preclinical evidence and potential clinical applications.
Med Oncol
; 35(1): 4, 2017 Dec 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29209837
17.
Cardiotoxicity of Aromatase Inhibitors in Breast Cancer Patients.
Clin Breast Cancer
; 17(1): 11-17, 2017 02.
Artigo
Inglês
| MEDLINE | ID: mdl-27561703
18.
Development of new first-line therapeutic options for non-small-cell lung cancer.
Lung Cancer
; 54 Suppl 2: S19-24, 2006 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-17056151
19.
Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Multicenter HERLAPAC Study.
PLoS One
; 11(5): e0156221, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27224517
20.
Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrence.
Tumori
; 101(4): 398-403, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26045108